BEDFORD, Mass., March 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the Osteoarthritis Pain Management and Regenerative Solutions space focused on early ...

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid ...

Going forward, our continuing operations will reflect the core products serve Anika's hyaluronic acid future, and key reconciliations to quarter results are provided in the appendix materials of ...

21 Anika Therapeutics, Inc. (NASDAQ:ANIK) is a global joint preservation company specializing in early intervention ...

The switch to Unanet will allow Anika Systems to more easily manage its financials through efficient reporting and empowering employees to contribute to the company's growth. "One of our company's ...

This acquisition significantly expands Medacta’s sports medicine offering. In total, Parcus brings more than 400 products ...

Anika Therapeutics, Inc ... These divestitures align with our focus to capitalize on our core HA products that provide us with the best value building opportunities, including the integrity ...